semaglutide bottle | NextGenRx Compound Pharmacy Compounded Semaglutide (GLP-1) - 4th

For compounding pharmacies or physicians that have been compounding semaglutide products during the shortage, the FDA has set clear deadlines for ceasing general semaglutide compounding practices: State-licensed pharmacies or physicians compounding semaglutide under Section 503A of the FD&C Act must stop compounding, distributing, or dispensing semaglutide injections that are essentially copies of an FDA-approved product by April 22, 2025

We review your health history, current medications, lifestyle, and wellness goals

This is due to lower overhead costs, a highly competitive aesthetic market, and internationally trained medical professionals

The schedule below assumes the separate-vial approach, which is also what the staggered titration is built around